{"id":"df1f035c7c5e","type":"article","url":"https://hartvaat.nl/2026/12/01/expertadvies-over-sportdeelneming-bij-myocarditis-en-klepziekten/","title":"Expertadvies over sportdeelneming bij myocarditis en klepziekten","title_en":"Task Force 5: Clinical Considerations for Myocarditis and Selected Cardiovascular Conditions, Including Valvular Heart Disease.","category":"hartfalen","category_label":"Hartfalen","professions":["cardioloog"],"tags":[],"journal":"Medicine and science in sports and exercise","doi":"10.1249/MSS.0000000000004093","source_url":"https://doi.org/10.1249/MSS.0000000000004093","authors":["James Sawalla Guseh","Larry A Allen","Silvia Castelletti","Aaron L Baggish","Benjamin D Levine","Jonathan H Kim","Matthias Wilhelm","Matthew W Martinez"],"significance":6,"published":"2026-11-22","source_date":"2026-12-01","image":"https://hartvaat.nl/global/img/6e2cc0469790.webp","kennis":["https://hartvaat.nl/kennis/hartfalen/palliatief-hartfalen/","https://hartvaat.nl/kennis/diagnostiek/cardiale-mri/"],"congress":"","summary_en":"An AHA/ACC task force has published a consensus document outlining clinical considerations for athletes with acquired cardiovascular conditions, including myocarditis, pericarditis, valvular heart disease, and infiltrative cardiomyopathies. The guidance emphasizes disease-specific risk stratification and shared decision-making to determine return-to-play eligibility. It provides cardiologists with a structured framework for evaluating and managing young athletes with these conditions in competitive sports settings.","created":"2026-11-15T02:34:14Z","updated":"2026-11-15T02:34:17Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Een task force van de AHA/ACC publiceert een consensusdocument over de medische evaluatie van atleten met verworven hartafwijkingen, waaronder myocarditis, pericarditis, klepziekten en infiltratieve cardiomyopathieën. Het document benadrukt disease-specifieke risicostratificatie en gedeelde besluitvorming om de geschiktheid voor competitief sporten en return-to-play te bepalen. Voor cardiologen biedt het een gestructureerd kader voor klinische afwegingen en follow-up bij jonge sporters met deze aandoeningen.","abstract_original":"Athletes with myocarditis, pericarditis, valvular heart disease, and other acquired cardiovascular conditions require careful evaluation when considering competitive sports participation. This document outlines key clinical considerations, risk factors, and expert consensus, serving as the rationale for Section V of the recent AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes with Cardiovascular Abnormalities. Disease-specific risk stratification and shared decision-making are essential in determining return-to-play eligibility. This Task Force document addresses myocarditis, pericarditis, the cardiovascular impact of respiratory viral infections, incidental myocardial fibrosis, Kawasaki disease, infiltrative cardiomyopathies, and valvular heart disease."}